+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Sentinel node biopsy and neoadjuvant chemotherapy in the treatment of breast cancer



Sentinel node biopsy and neoadjuvant chemotherapy in the treatment of breast cancer



Journal of BUON 17(2): 265-270



Sentinel lymph node biopsy (SLNB) has become a safe and accurate alternative to axillary lymph node dissection (ALND) in the surgical management of early breast cancer. The aim of this study was to determine the false negative rate of SLNB in patients with advanced breast cancer after neoadjuvant chemotherapy. Forty-eight patients with 49 advanced breast cancers (one patient had bilateral disease) underwent neoadjuvant chemotherapy. All of them had SLNB, followed by standard level I/II ALND. SLNs were identified in 47 out of 49 tumors (detection rate 95.9%). Axillary nodal metastases were detected in 28 patients; SLNs were positive only in 14 patients. Four sentinel internal mammary nodes were removed in 4 patients, while one of them was positive with micrometastasis but axillary nodes were negative. False-negative results occurred in 2 (7.14%) patients. The results of our study confirm that SLNB in patients with advanced breast cancer is not significantly altered by the preoperative chemotherapy. Biopsy results were very similar to those without any neoadjuvant chemotherapy. ALND, known for its serious complications, can be replaced in some cases by SLNB.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 055715511

Download citation: RISBibTeXText

PMID: 22740204


Related references

Advantage of sentinel lymph node biopsy before neoadjuvant chemotherapy in breast cancer treatment. Surgery Today 39(5): 374-380, 2009

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. Journal of Clinical Oncology 33(3): 258-264, 2015

Sentinel lymph node biopsy for breast cancer after neoadjuvant chemotherapy: influence of nodal status before treatment. Bulletin du Cancer 93(4): 415-419, 2006

Meta-analysis of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initial biopsy-proven node-positive breast cancer. British Journal of Surgery 105(12): 1541-1552, 2018

Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatment. European Journal of Cancer 51(8): 915-921, 2015

Refining the Performance of Sentinel Lymph Node Biopsy Post-neoadjuvant Chemotherapy in Patients with Pathologically Proven Pre-treatment Node-positive Breast Cancer: An Update for Clinical Practice. Anticancer Research 36(4): 1461-1471, 2016

Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer. Annals of Surgical Oncology 13(4): 483-490, 2006

Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer. Clinical Breast Cancer 13(6): 471-477, 2013

III. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(13): 2568-2570, 2014

Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer. American Journal of Surgery 184(4): 315-317, 2002

Sentinel lymph node biopsy following neoadjuvant chemotherapy in clinically node-negative breast cancer patients. Journal of Clinical Oncology 29(27_Suppl): 15-15, 2016

Sentinel node biopsy prior to neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer. Annals of Surgical Oncology 11(2 Suppl.): S99-0, 2004

Sentinel Node Biopsy After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer: Does Axillary Ultrasound Improve Performance?. Journal of Clinical Oncology 33(30): 3375-3378, 2015

Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice. Asian Journal of Surgery 42(1): 314-319, 2019

Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection. Annals of Surgical Oncology 13(4): 475-479, 2006